PRVA vs. LFST, USPH, ALHC, PHR, CYRX, PNTG, INNV, GH, STAA, and DYN
Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include LifeStance Health Group (LFST), U.S. Physical Therapy (USPH), Alignment Healthcare (ALHC), Phreesia (PHR), Cryoport (CYRX), The Pennant Group (PNTG), InnovAge (INNV), Guardant Health (GH), STAAR Surgical (STAA), and Dyne Therapeutics (DYN).
LifeStance Health Group (NASDAQ:LFST) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.
Privia Health Group has a net margin of 1.11% compared to Privia Health Group's net margin of -15.69%. LifeStance Health Group's return on equity of 3.13% beat Privia Health Group's return on equity.
85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 6.6% of LifeStance Health Group shares are owned by insiders. Comparatively, 14.2% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
LifeStance Health Group has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.
Privia Health Group has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Privia Health Group had 19 more articles in the media than LifeStance Health Group. MarketBeat recorded 35 mentions for Privia Health Group and 16 mentions for LifeStance Health Group. Privia Health Group's average media sentiment score of 0.26 beat LifeStance Health Group's score of 0.23 indicating that LifeStance Health Group is being referred to more favorably in the media.
Privia Health Group received 45 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 73.33% of users gave Privia Health Group an outperform vote while only 26.32% of users gave LifeStance Health Group an outperform vote.
LifeStance Health Group presently has a consensus price target of $8.80, indicating a potential upside of 17.49%. Privia Health Group has a consensus price target of $25.33, indicating a potential upside of 45.85%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, analysts plainly believe Privia Health Group is more favorable than LifeStance Health Group.
Summary
Privia Health Group beats LifeStance Health Group on 15 of the 18 factors compared between the two stocks.
Get Privia Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Privia Health Group Competitors List
Related Companies and Tools
